# AbbVie Inc. (ABBV) — Q2-2017 Earnings Results

**Report date:** 2017-07-28 (before market open)  
**Sector:** Health Care / Biotechnology  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/ABBV/earnings/Q2-2017

## Post-Earnings Brief

### Headline

AbbVie Beats on EPS, Stock Down 1.8%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.42 | N/A | +0.06% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Cautiously Optimistic

Overall, management conveyed a positive outlook on their product pipeline. However, the lack of specific guidance may have left some investors uncertain.

**Key quotes:**

> Management expressed confidence in the pipeline but did not provide specific guidance.

> They highlighted ongoing investments in research and development.

### Guidance Changes

No guidance was provided during the earnings call.

### What It Means

AbbVie's earnings report showed a slight beat on EPS, which is a positive sign for the company. However, the stock fell by 1.8% likely due to the absence of revenue details and future guidance. Investors may be cautious as they await more information on the company's performance and strategy moving forward.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/ABBV/earnings/Q2-2017_